Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dan Jones

Showing results (191-200 of 278) with videos related to

Pageof 28
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 17, 2009
Results of dasatinib therapy in patients with early chronic-phase chronic myeloid leukemiaJorge E Cortes, Dan Jones, Susan O'Brien, et al.
Metabolites|January 18, 2020
Phytohormone and Transcriptomic Analysis Reveals Endogenous Cytokinins Affect Kiwifruit Growth under Restricted Carbon SupplySimona Nardozza, Janine Cooney, Helen L Boldingh, et al.
Blood|April 8, 2006
Allogeneic stem cell transplantation for patients with chronic myeloid leukemia and acute lymphocytic leukemia after Bcr-Abl kinase mutation-related imatinib failureElias Jabbour, Jorge Cortes, Hagop M Kantarjian, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 15, 2020
Activation of the RAS pathway through uncommon BRAF mutations in mucinous pancreatic cysts without KRAS mutationRongqin Ren, Somashekar G Krishna, Wei Chen, et al.
British Journal of Haematology|May 22, 2008
Splenic marginal zone lymphomas are characterized by loss of interstitial regions of chromosome 7q, 7q31.32 and 7q36.2 that include the protection of telomere 1 (POT1) and sonic hedgehog (SHH) genesFrancisco Vega, Jeong Hee Cho-Vega, Patrick A Lennon, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 9, 2005
T cell leukemia-1 modulates TCR signal strength and IFN-gamma levels through phosphatidylinositol 3-kinase and protein kinase C pathway activationKatrina K Hoyer, Marco Herling, Ksenia Bagrintseva, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 17, 2009
Nilotinib as front-line treatment for patients with chronic myeloid leukemia in early chronic phaseJorge E Cortes, Dan Jones, Susan O'Brien, et al.
Journal of Occupational and Environmental Medicine|March 20, 2021
Benchmarking SARS CoV-2 Infection in the Workplace to Support Continuity of OperationsBart O Iddins, Mark H Waugh, Brandon Buck, et al.
Cell Reports|May 18, 2022
H3-K27M-mutant nucleosomes interact with MLL1 to shape the glioma epigenetic landscapeNoa Furth, Danielle Algranati, Bareket Dassa, et al.
Cancer|July 11, 2008
Kinase domain point mutations in Philadelphia chromosome-positive acute lymphoblastic leukemia emerge after therapy with BCR-ABL kinase inhibitorsDan Jones, Deborah Thomas, C Cameron Yin, et al.
Pageof 28

Showing results (191-200 of 278) with videos related to

Sort By:
Pageof 28
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 17, 2009
Results of dasatinib therapy in patients with early chronic-phase chronic myeloid leukemiaJorge E Cortes, Dan Jones, Susan O'Brien, et al.
Metabolites|January 18, 2020
Phytohormone and Transcriptomic Analysis Reveals Endogenous Cytokinins Affect Kiwifruit Growth under Restricted Carbon SupplySimona Nardozza, Janine Cooney, Helen L Boldingh, et al.
Blood|April 8, 2006
Allogeneic stem cell transplantation for patients with chronic myeloid leukemia and acute lymphocytic leukemia after Bcr-Abl kinase mutation-related imatinib failureElias Jabbour, Jorge Cortes, Hagop M Kantarjian, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 15, 2020
Activation of the RAS pathway through uncommon BRAF mutations in mucinous pancreatic cysts without KRAS mutationRongqin Ren, Somashekar G Krishna, Wei Chen, et al.
British Journal of Haematology|May 22, 2008
Splenic marginal zone lymphomas are characterized by loss of interstitial regions of chromosome 7q, 7q31.32 and 7q36.2 that include the protection of telomere 1 (POT1) and sonic hedgehog (SHH) genesFrancisco Vega, Jeong Hee Cho-Vega, Patrick A Lennon, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 9, 2005
T cell leukemia-1 modulates TCR signal strength and IFN-gamma levels through phosphatidylinositol 3-kinase and protein kinase C pathway activationKatrina K Hoyer, Marco Herling, Ksenia Bagrintseva, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 17, 2009
Nilotinib as front-line treatment for patients with chronic myeloid leukemia in early chronic phaseJorge E Cortes, Dan Jones, Susan O'Brien, et al.
Journal of Occupational and Environmental Medicine|March 20, 2021
Benchmarking SARS CoV-2 Infection in the Workplace to Support Continuity of OperationsBart O Iddins, Mark H Waugh, Brandon Buck, et al.
Cell Reports|May 18, 2022
H3-K27M-mutant nucleosomes interact with MLL1 to shape the glioma epigenetic landscapeNoa Furth, Danielle Algranati, Bareket Dassa, et al.
Cancer|July 11, 2008
Kinase domain point mutations in Philadelphia chromosome-positive acute lymphoblastic leukemia emerge after therapy with BCR-ABL kinase inhibitorsDan Jones, Deborah Thomas, C Cameron Yin, et al.
Pageof 28